Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/03/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 300 | $181.08 | $54.3k | | 08/02/2023 |
08/03/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 1.5k | $184.89 | $283.8k | | 08/02/2023 |
08/03/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 1.7k | $185.99 | $318.8k | | 08/02/2023 |
08/03/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 500 | $182.45 | $91.2k | | 08/02/2023 |
08/03/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 560 | $183.75 | $102.9k | | 08/02/2023 |
08/03/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 1.4k | $187.04 | $259.8k | | 08/02/2023 |
08/03/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 450 | $187.71 | $84.5k | | 08/02/2023 |
08/02/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Restricted Stock Units | 22.5k | $0.00 | $0 | | 08/02/2023 |
05/18/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 3.5k | $189.87 | $655.8k | | 05/18/2023 |
08/02/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Restricted Stock Units | 22.5k | $0.00 | $0 | | 08/02/2021 |
07/15/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4k | $171.95 | $693.3k | | 07/15/2021 |
06/30/2021 | Kaleido Biosciences, Inc. | KLDO | Grant | Stock Option (Right to Buy) | 15k | $7.44 | $111.6k | | 06/30/2021 |
06/13/2021 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 902 | $0.00 | $0 | | 06/13/2021 |
06/03/2021 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 2.9k | $0.00 | $0 | | 06/03/2021 |
06/01/2021 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 18.2k | $12.91 | $234.8k | | 06/01/2021 |
02/01/2021 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 3.1k | $62.21 | $190k | | 02/01/2021 |
12/31/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 371.997 | $62.03 | $23.1k | | 12/31/2020 |
09/30/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 382.733 | $60.29 | $23.1k | | 09/30/2020 |
07/01/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4.6k | $148.77 | $681.5k | | 07/01/2020 |
06/30/2020 | Kaleido Biosciences, Inc. | KLDO | Grant | Stock Option (Right to Buy) | 15k | $0.00 | $0 | | 06/30/2021 |
06/30/2020 | Kaleido Biosciences, Inc. | KLDO | Grant | Stock Option (Right to Buy) | 15k | $7.42 | $111.3k | | 06/30/2020 |
06/30/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 392.432 | $58.80 | $23.1k | | 06/30/2020 |
06/14/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 558 | $0.00 | $0 | | 06/13/2020 |
06/13/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 903 | $0.00 | $0 | | 06/13/2020 |
06/05/2020 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 18.2k | $9.99 | $181.7k | | 06/05/2020 |
06/03/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 2.9k | $0.00 | $0 | | 06/03/2020 |
03/31/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 413.976 | $55.74 | $23.1k | | 03/31/2020 |
02/28/2020 | Sarepta Therapeutics, Inc. | SRPT | Grant | Common Stock | 2.1k | $0.00 | $0 | | 02/28/2020 |
02/28/2020 | Sarepta Therapeutics, Inc. | SRPT | Grant | Stock option (right to buy) | 3.7k | $114.47 | $421.8k | | 02/28/2020 |
02/01/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 3k | $62.95 | $190k | | 02/01/2020 |
12/31/2019 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 126.239 | $64.19 | $8.1k | | 12/31/2019 |
12/04/2019 | BRISTOL MYERS SQUIBB CO | BMY | Purchase | Common Stock, $0.10 par value | 88 | $58.90 | $5.2k | | 12/04/2019 |
11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Common Stock | 2.2k | $0.00 | $0 | | 11/20/2019 |
11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Common Stock | 2k | $0.00 | $0 | Trust | 11/20/2019 |
11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Stock Option (right to buy) | 10k | $115.78 | $1.2M | | 11/20/2019 |
|